drugset / Trial / NCT04692376
MSC for Treatment of cGVHD After Allo-HSCT
Phase 2
Unknown
152 enrolled
Nanfang Hospital, Southern Medical University
Army Medical University, China · collabPeking University People's Hospital · collabSun Yat-sen University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy of mesenchymal stem cells in patients with chronic graft-versus-host disease.
Timeline
- Start
- 2021-01-10
- Primary completion
- 2022-12-31
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Background | Cyclosporine | Peptide | 2.5 mg/kg | — |
| Background | Methylprednisolone | Other / unclassified | 1 mg/kg | — |